跳至主要内容
临床试验/PACTR202401622249032
PACTR202401622249032已完成3 期

Comparative study of the safety and efficacy of levofloxacin and ciprofloxacin in the treatment of community-acquired, bacterial urinary tract infection among patients with chronic kidney disease

Dhikrullah Adebayo0 个研究点目标入组 90 人开始时间: 2023年12月5日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • 1.Age 18years and above.
  • 2.Known CKD patients
  • 3.Symptoms compatible with a diagnosis of UTI plus positive dipstick test for pyuria
  • 4.Informed consent to participate in the study.

排除标准

  • 1.Patients with any rapidly progressive or terminal disease
  • 2.Individuals with prior renal transplantation.
  • 3.Co-existence of other infections in addition to urinary tract infection
  • 4.Exposure to any antimicrobial prior to presentation
  • 5.Known previous reaction to quinolones.
  • 6.Hospital acquired UTI
  • 7.Catheter associated UTI

研究者

发起方
Dhikrullah Adebayo

相似试验

Comparative study of the safety and efficacy of... | 临床试验